Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Value of pharmaceutical sales in Norway from 2000 to 2017
(in milllion NOK)
Value of pharmaceutical sales in Norway 2000-2017
The sales of pharmaceuticals in Norway reached their highest ever value in 2017, of almost 27 billion Norwegian kroner. The value was reached after it had increased almost annually since 2000, except for a slight decrease in 2010. Prescription pharmaceuticals generated the highest turnover, of around 23.8 billion Norwegian kroner.

Generic pharmaceuticals in Norway

   On average, the market share of generic drugs in the Norwegian pharmaceutical market increased since 2001 and peaked in 2016 with 49.4 percent. In 2017, their market share had decreased slightly, down to 49.1 percent. A generic drug can enter the market when the patent of a previously patented drug has expired. They are copies of brand-name drugs and contains the same chemical substance.

Pharmaceutical companies

  The pharmaceutical market in Norway is dominated by major international companies with branches in Norway. The leading pharmaceutical company in Norway in 2018 was Pfizer AS, with a market share of 6.2 percent, and was followed by MSD (Norge) AS and Novartis Norge AS, with six and 5.9 percent of the market respectively. Pfizer AS had the highest turnover of pharmaceutical companies in Norway that year, of around 1.5 billion Norwegian kroner.
Value of pharmaceutical sales in Norway from 2000 to 2017
(in milllion NOK)
Sales in million Norwegian kroner
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

April 2019

Region

Norway

Survey time period

2000 to 2017

Supplementary notes

Release date is the date of data extraction.

Value of pharmaceutical sales in Norway 2000-2017
The sales of pharmaceuticals in Norway reached their highest ever value in 2017, of almost 27 billion Norwegian kroner. The value was reached after it had increased almost annually since 2000, except for a slight decrease in 2010. Prescription pharmaceuticals generated the highest turnover, of around 23.8 billion Norwegian kroner.

Generic pharmaceuticals in Norway

   On average, the market share of generic drugs in the Norwegian pharmaceutical market increased since 2001 and peaked in 2016 with 49.4 percent. In 2017, their market share had decreased slightly, down to 49.1 percent. A generic drug can enter the market when the patent of a previously patented drug has expired. They are copies of brand-name drugs and contains the same chemical substance.

Pharmaceutical companies

  The pharmaceutical market in Norway is dominated by major international companies with branches in Norway. The leading pharmaceutical company in Norway in 2018 was Pfizer AS, with a market share of 6.2 percent, and was followed by MSD (Norge) AS and Novartis Norge AS, with six and 5.9 percent of the market respectively. Pfizer AS had the highest turnover of pharmaceutical companies in Norway that year, of around 1.5 billion Norwegian kroner.
Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Statistics on "Pharmaceutical industry in Norway "
  • Overview
The most important statistics
  • Production and trade
  • Pharmaceutical turnover
  • R&D, patents and new products
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.